Research material
Research-grade protein, His-tagged, within a week. Express/reject per construct, estimated yield, gel image.
For AI × Bio, Academic labs, Rare disease therapeutic developers, Orphan drug biosimilar sponsors
One cell-free process that serves the whole pipeline, from R&D to clinical manufacturing at kg scale. Every capability carries a status: open now, in development or planned.
Research-grade protein, His-tagged, within a week. Express/reject per construct, estimated yield, gel image.
For AI × Bio, Academic labs, Rare disease therapeutic developers, Orphan drug biosimilar sponsors
An in-house lab with co-developed protocols runs validation assays directly from the pipeline. Results leave over the API, into your stack.
For AI × Bio
The same process, scaled: what you validated early predicts the batch you file with. No process transfer, no re-validation cliff.
For Rare disease therapeutic developers, Orphan drug biosimilar sponsors
Guaranteeing patient access by insourcing production of key material.
For Governments & agencies
Paired formats, enzyme complexes and multi-subunit targets, co-expressed on one process.
For AI × Bio, Academic labs
Custom research material is open now — send the protein sequence and we make it. An off-the-shelf library is on its way.